OSE IMMUNOTHERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.75 EUR | -3.57% |
|
+8.87% | +57.71% |
| Apr. 17 | OSE: licensing agreement with AbbVie enters into force | CF |
| Apr. 17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Other Biotechnology & Medical Research | -3.57% | +8.87% | +57.71% | +73.52% | +78.57% | 157M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- OSE Stock
- Charts OSE Immunotherapeutics
- Comparison Chart